DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Fosbretabulin is an investigational drug.
There have been 18 clinical trials for Fosbretabulin. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2015.
The most common disease conditions in clinical trials are Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic, and Ovarian Neoplasms. The leading clinical trial sponsors are Mateon Therapeutics, National Cancer Institute (NCI), and Case Comprehensive Cancer Center.
There are three hundred and eighty-nine US patents protecting this investigational drug and two international patents.
Recent Clinical Trials for Fosbretabulin
|Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression||Lowell Anthony, MD||Phase 1|
|FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer||Mateon Therapeutics||Phase 2/Phase 3|
|Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer||Mateon Therapeutics||Phase 3|
Top disease conditions for Fosbretabulin
Top clinical trial sponsors for Fosbretabulin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Fosbretabulin||⤷ Try it Free||Pyrrolidinone derivatives as MetAP-2 inhibitors||Merck Patent GmbH (Darmstadt, DE)||⤷ Try it Free|
|Fosbretabulin||⤷ Try it Free||Pharmaceutical compositions||Momenta Pharmaceuticals, Inc. (Cambridge, MA)||⤷ Try it Free|
|Fosbretabulin||⤷ Try it Free||Small molecule drug conjugates||Eth Zurich (Zurich, CH)||⤷ Try it Free|
|Fosbretabulin||⤷ Try it Free||Anti-vasculature and anti-tubulin combretastatin analogs for treatment of cancer||XAVIER UNIVERSITY OF LOUSIANA (New Orleans, LA)||⤷ Try it Free|
|Fosbretabulin||⤷ Try it Free||Heteroaryl compounds as IRAK inhibitors and uses thereof||Merck Patent GmbH (Darmstadt, DE)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Fosbretabulin||Argentina||AR101414||2034-08-04||⤷ Try it Free|
|Fosbretabulin||Australia||AU2015299431||2034-08-04||⤷ Try it Free|
|Fosbretabulin||Brazil||BR112017000730||2034-08-04||⤷ Try it Free|
|Fosbretabulin||Canada||CA2957154||2034-08-04||⤷ Try it Free|
|Fosbretabulin||China||CN106660989||2034-08-04||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|